A
new departure. In addition to biomedical patents, Monty's service
begins to summarise articles in specialist journals, conferences
proceedings, etc.
This is at the request of pharmaceutical
firms, including Bayer, Merck and Ciba (now Novartis) who had been
carrying out this work themselves, but the workload had grown
too
much.
The customers in this case have come to Monty, such is now the
reputation of Derwent!
Later
renamed 'Derwent Drug File' this and other literature services are
today integral also to the Clarivate Cortellis service.